e-Drug3D 767 |
REMIFENTANIL
|
cas 132875-61-7 |
CLASS NERVOUS SYSTEM |
ROUTE (list) INJECTION |
ATC code |
PK parameters VD 22.7 LITER (65 KILOGRAM) |
Target TARGET MU-TYPE OPIOID RECEPTOR |
DrugCentral Mu-type opioid receptor UNIPROT P35372 OPRM1 |
Download SDF file | methyl 1-(3-methoxy-3-oxopropyl)-4-(phenyl-propanoylamino)piperidine-4-carboxylate Formula: Calculated chemical properties: MW 376.44 NB_atoms 27 XLogP 2.00 PSA 68.871 NB_HD 0 NB_HA 7 fsp3 0.55 Lipinski(0=no;1=yes) 1 |
FDA NDA 020630 (pdf not found) INN (REMIFENTANIL HYDROCHLORIDE) ULTIVA (MYLAN INSTITUTIONAL) APPROVAL= AP YEAR= 1996 NDA 206223 (pdf not found) INN (REMIFENTANIL HYDROCHLORIDE) REMIFENTANIL HYDROCHLORIDE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2018 NDA 210594 (pdf not found) INN (REMIFENTANIL HYDROCHLORIDE) REMIFENTANIL HYDROCHLORIDE (HIKMA) APPROVAL= AP YEAR= 2020 NDA 215635 (pdf not found) INN (REMIFENTANIL HYDROCHLORIDE) REMIFENTANIL HYDROCHLORIDE (NIVAGEN PHARMS INC) APPROVAL= AP YEAR= 2024 |
Other links: |